
Associate Professor Kerrie McDonald
Contact Details
Phone: 93851471
Fax: 51510
Email: k.mcdonald@unsw.edu.au
Tabs
Publications related to this Person
Journal articles
Barthel FP; Johnson KC; Varn FS; Moskalik AD; Tanner G; Kocakavuk E; Anderson KJ; Abiola O; Aldape K; Alfaro KD; Alpar D; Amin SB; Ashley DM; Bandopadhayay P; Barnholtz-Sloan JS; Beroukhim R; Bock C; Brastianos PK; Brat DJ; Brodbelt AR; Bruns AF; Bulsara KR; Chakrabarty A; Chakravarti A; Chuang JH; Claus EB; Cochran EJ; Connelly J; Costello JF; Finocchiaro G; Fletcher MN; French PJ; Gan HK; Gilbert MR; Gould PV; Grimmer MR; Iavarone A; Ismail A; Jenkinson MD; Khasraw M; Kim H; Kouwenhoven MCM; Laviolette PS; Li M; Lichter P; Ligon KL; Lowman AK; Malta TM; Mazor T; McDonald KL; Molinaro AM; Nam DH; Nayyar N; Ng HK; Ngan CY; Niclou SP; Niers JM; Noushmehr H; Noorbakhsh J; Ormond DR; Park CK; Poisson LM; Rabadan R; Radlwimmer B; Rao G; Reifenberger G; Sa JK; Schuster M; Shaw BL; Short SC; Sillevis Smitt PA; Sloan AE; Smits M; Suzuki H; Tabatabai G; Van Meir EG; Watts C; Weller M; Wesseling P; Westerman BA; Widhalm G; Woehrer A; Yung WKA; Zadeh G; Huse JT; de Groot JF; Stead LF; Verhaak RGW, 2019, 'Longitudinal molecular trajectories of diffuse glioma in adults', Nature, vol. 576, pp. 112 - 120, http://dx.doi.org/10.1038/s41586-019-1775-1
Ha W; Sevim-Nalkiran H; Zaman AM; Matsuda K; Khasraw M; Nowak AK; Chung L; Baxter RC; McDonald KL, 2019, 'Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)', Scientific Reports, vol. 9, http://dx.doi.org/10.1038/s41598-019-39427-4
Zheng M; Jiang T; Yang W; Zou Y; Wu H; Liu X; Zhu F; Qian R; Ling D; McDonald K; Shi J; Shi B, 2019, 'The siRNAsome: A Cation-Free and Versatile Nanostructure for siRNA and Drug Co-delivery', Angewandte Chemie - International Edition, vol. 58, pp. 4938 - 4942, http://dx.doi.org/10.1002/anie.201814289
Lu VM; Alvi MA; McDonald KL; Daniels DJ, 2019, 'Impact of the H3K27M mutation on survival in pediatric high-grade glioma: A systematic review and meta-analysis', Journal of Neurosurgery: Pediatrics, vol. 23, pp. 308 - 316, http://dx.doi.org/10.3171/2018.9.PEDS18419
Lu VM; Goyal A; Rovin RA; Lee A; McDonald KL, 2019, 'Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis', Journal of Neuro-Oncology, vol. 141, pp. 1 - 12, http://dx.doi.org/10.1007/s11060-018-03020-y
Jue TR; Olafson LR; Siddell AH; Rapkins RW; Ng B; Yin JXM; Lu VM; Chung SA; Whittaker SP; Davies M; Fairhall JM; Hovey EJ; McDonald KL, 2019, 'A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype', Cold Spring Harbor Molecular Case Studies, vol. 5, http://dx.doi.org/10.1101/mcs.a003251
Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS, 2018, 'Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer', Cancer Biology and Therapy, vol. 19, pp. 1078 - 1087, http://dx.doi.org/10.1080/15384047.2018.1491498
Lu VM; Texakalidis P; McDonald KL; Mekary RA; Smith TR, 2018, 'The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis', Clinical Neurology and Neurosurgery, vol. 174, pp. 149 - 155, http://dx.doi.org/10.1016/j.clineuro.2018.09.019
Lu VM; Phan K; Yin JXM; McDonald KL, 2018, 'Older studies can underestimate prognosis of glioblastoma biomarker in meta-analyses: a meta-epidemiological study for study-level effect in the current literature', Journal of Neuro-Oncology, vol. 139, pp. 231 - 238, http://dx.doi.org/10.1007/s11060-018-2897-2
Lu VM; Goyal A; Vaughan LS; McDonald KL, 2018, 'The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis', Clinical Neurology and Neurosurgery, vol. 170, pp. 165 - 169, http://dx.doi.org/10.1016/j.clineuro.2018.05.020
Lu VM; Jue TR; McDonald KL; Rovin RA, 2018, 'The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis', World Neurosurgery, vol. 115, pp. 453 - 459.e3, http://dx.doi.org/10.1016/j.wneu.2018.04.016
de Souza CF; Sabedot TS; Malta TM; Stetson L; Morozova O; Sokolov A; Laird PW; Wiznerowicz M; Iavarone A; Snyder J; deCarvalho A; Sanborn Z; McDonald KL; Friedman WA; Tirapelli D; Poisson L; Mikkelsen T; Carlotti CG; Kalkanis S; Zenklusen J; Salama SR; Barnholtz-Sloan JS; Noushmehr H, 2018, 'A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence', Cell Reports, vol. 23, pp. 637 - 651, http://dx.doi.org/10.1016/j.celrep.2018.03.107
Phan K; Ng W; Lu VM; McDonald KL; Fairhall J; Reddy R; Wilson P, 2018, 'Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis', World Neurosurgery, vol. 111, pp. e539 - e545, http://dx.doi.org/10.1016/j.wneu.2017.12.112
Felthun J; Reddy R; McDonald KL, 2018, 'How immunotherapies are targeting the glioblastoma immune environment', Journal of Clinical Neuroscience, vol. 47, pp. 20 - 27, http://dx.doi.org/10.1016/j.jocn.2017.10.019
Lu VM; Jue TR; Phan K; McDonald KL, 2018, 'Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: A systematic review and meta-analysis', Clinical Neurology and Neurosurgery, vol. 164, pp. 75 - 80, http://dx.doi.org/10.1016/j.clineuro.2017.11.015
Jue TR; Sena ES; Macleod MR; McDonald KL; Hirst TC, 2018, 'A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models', Oncotarget, vol. 9, pp. 11387 - 11401, http://dx.doi.org/10.18632/oncotarget.24334
Lu VM; McDonald KL, 2018, 'Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma', CNS oncology, vol. 7, pp. 41 - 50, http://dx.doi.org/10.2217/cns-2017-0019
Lu VM; McDonald KL; Townley HE, 2017, 'Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma', Nanomedicine, vol. 12, pp. 2389 - 2401, http://dx.doi.org/10.2217/nnm-2017-0193
Lu VM; McDonald KL, 2017, 'The current evidence of statin use affecting glioblastoma prognosis', Journal of Clinical Neuroscience, vol. 42, pp. 196 - 197, http://dx.doi.org/10.1016/j.jocn.2017.04.036
Sinnadurai M; McDonald KL, 2017, 'Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma', Journal of Neuro-Oncology, vol. 132, pp. 359 - 372, http://dx.doi.org/10.1007/s11060-017-2390-3
Nalkiran HS; McDonald KL, 2017, 'Is neuroglial antigen 2 a potential contributor to cilengitide response in glioblastoma?', Journal of Cancer Research and Therapeutics, vol. 13, pp. 329 - 336, http://dx.doi.org/10.4103/0973-1482.188438
Jue TR; Nozue K; Lester AJ; Joshi S; Schroder LBW; Whittaker SP; Nixdorf S; Rapkins RW; Khasraw M; McDonald KL, 2017, 'Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma', Journal of Translational Medicine, vol. 15, http://dx.doi.org/10.1186/s12967-017-1164-1
Lester A; Rapkins R; Nixdorf S; Khasraw M; McDonald K, 2017, 'Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?', Clinical and Translational Oncology, vol. 19, pp. 273 - 278, http://dx.doi.org/10.1007/s12094-016-1547-4
Greenall SA; Lim YC; Mitchell CB; Ensbey KS; Stringer BW; Wilding AL; O'Neill GM; McDonald KL; Gough DJ; Day BW; Johns TG, 2017, 'Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma', Oncogenesis, vol. 6, http://dx.doi.org/10.1038/oncsis.2017.33
Jue TR; McDonald KL, 2016, 'The challenges associated with molecular targeted therapies for glioblastoma', Journal of Neuro-Oncology, vol. 127, pp. 427 - 434, http://dx.doi.org/10.1007/s11060-016-2080-6
Hau E; Shen H; Clark C; Graham PH; Koh ES; L Mcdonald K, 2016, 'The evolving roles and controversies of radiotherapy in the treatment of glioblastoma', Journal of Medical Radiation Sciences, vol. 63, pp. 114 - 123, http://dx.doi.org/10.1002/jmrs.149
Rapkins RW; Wang F; Nguyen HTN; Cloughesy TF; Lai A; Ha W; Nowak AK; Hitchins MP; McDonald KL, 2015, 'The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide', Neuro-Oncology, vol. 17, pp. 1589 - 1598, http://dx.doi.org/10.1093/neuonc/nov064
Shen H; Hau E; Joshi S; Dilda PJ; McDonald KL, 2015, 'Sensitization of glioblastoma cells to irradiation by modulating the glucose metabolism', Molecular Cancer Therapeutics, vol. 14, pp. 1794 - 1804, http://dx.doi.org/10.1158/1535-7163.MCT-15-0247
Mallawaaratchy DM; Buckland ME; McDonald KL; Li CCY; Ly L; Sykes EK; Christopherson RI; Kaufman KL, 2015, 'Membrane Proteome Analysis of Glioblastoma Cell Invasion', Journal of Neuropathology and Experimental Neurology, vol. 74, pp. 425 - 441, http://dx.doi.org/10.1097/NEN.0000000000000187
Shen H; Decollogne S; Dilda P; Hau E; Chung S; Luk P; Hogg PJ; McDonald KL, 2015, 'Dual-targeting of aberrant glucose metabolism in glioblastoma', Journal of Experimental & Clinical Cancer Research, vol. 34, http://dx.doi.org/10.1186/s13046-015-0130-0
Jue TR; Hovey E; Davis S; Carleton O; McDonald KL, 2015, 'Incorporation of biomarkers in phase II studies of recurrent glioblastoma', Tumor Biology, vol. 36, pp. 153 - 162, http://dx.doi.org/10.1007/s13277-014-2960-3
McDonald KL; Tabone T; Nowak AK; Erber WN, 2015, 'Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation', Oncology Letters, vol. 9, pp. 2063 - 2067, http://dx.doi.org/10.3892/ol.2015.2980
Schröder LBW; McDonald KL, 2015, 'CDK4/6 inhibitor PD0332991 in glioblastoma treatment: Does it have a future?', Frontiers in Oncology, vol. 5, http://dx.doi.org/10.3389/fonc.2015.00259
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ, 2014, 'Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology', PLOS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0112945
Damodaran O; Van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G, 2014, 'Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy', Journal of Clinical Neuroscience, vol. 21, pp. 478 - 481, http://dx.doi.org/10.1016/j.jocn.2013.07.042
Tabone T; Abuhusain HJ; Nowak AK; Erber WN; McDonald KL, 2014, 'Multigene profiling to identify alternative treatment options for glioblastoma: A pilot study', Journal of Clinical Pathology, vol. 67, pp. 550 - 555, http://dx.doi.org/10.1136/jclinpath-2014-202173
Tivnan A; Zhao J; Johns TG; Day BW; Stringer BW; Boyd AW; Tiwari S; Giles KM; Teo C; McDonald KL, 2014, 'The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma', Tumor Biology, vol. 35, pp. 1459 - 1465, http://dx.doi.org/10.1007/s13277-013-1200-6
Ohta T; Kim YH; Oh JE; Satomi K; Nonoguchi N; Keyvani K; Pierscianek D; Sure U; Mittelbronn M; Paulus W; Vital A; Yokoo H; McDonald K; Kleihues P; Nazaret N; Barbet F; Lachuer J; Ohgaki H, 2014, 'Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas', Journal of Neuropathology and Experimental Neurology, vol. 73, pp. 908 - 915, http://dx.doi.org/10.1097/NEN.0000000000000110
Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS, 2013, 'A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis', Journal of Biological Chemistry, vol. 288, pp. 37355 - 37364, http://dx.doi.org/10.1074/jbc.M113.494740
Yeung YT; McDonald KL; Grewal T; Munoz L, 2013, 'Interleukins in glioblastoma pathophysiology: Implications for therapy', British Journal of Pharmacology, vol. 168, pp. 591 - 606, http://dx.doi.org/10.1111/bph.12008
Kast RE; Boockvar JA; Brüning A; Cappello F; Chang WW; Cvek B; Dou QP; Duenas-Gonzalez A; Efferth T; Focosi D; Ghaffari SH; Karpel-Massler G; Ketola K; Khoshnevisan A; Keizman D; Magné N; Marosi C; McDonald K; Muñoz M; Paranjpe A; Pourgholami MH; Sardi I; Sella A; Srivenugopal KS; Tuccori M; Wang W; Wirtz CR; Halatsch ME, 2013, 'A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care', Oncotarget, vol. 4, pp. 502 - 530, http://dx.doi.org/10.18632/oncotarget.969
Tivnan A; McDonald KL, 2013, 'Current progress for the use of miRNAs in glioblastoma treatment', Molecular Neurobiology, vol. 48, pp. 757 - 768, http://dx.doi.org/10.1007/s12035-013-8464-0
McDonald K; Aw G; Kleihues P, 2013, 'Role of biomarkers in the clinical management of glioblastomas: What are the barriers and how can we overcome them?', Frontiers in Neurology, vol. 3, pp. Article number 188, http://dx.doi.org/10.3389/fneur.2012.00188
Yeung Y; Bryce N; Adams S; Braidy N; Koyanagi M; McDonald K; Teo C; Watterson D; Guillemin GJ; Grewal T; Munoz L, 2012, 'p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and invasiveness of human glioblastoma cells', Journal of Neuro-Oncology, vol. 109, pp. 35 - 44, http://dx.doi.org/10.1007/s11060-012-0875-7
Wong JWH; Abuhusain H; McDonald K; Don AS, 2012, 'MMSAT: Automated Quantification of Metabolites in Selected Reaction Monitoring Experiments', Analytical Chemistry, vol. 84, pp. 470 - 474, http://dx.doi.org/10.1021/ac2026578
McDonald KL, 2011, 'DRIVING A MOTOR VEHICLE AFTER DIAGNOSIS OF A BRAIN TUMOR: A PRIVILEGE, NOT A RIGHT', NEURO-ONCOLOGY, vol. 13, pp. 125 - 126, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600495&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Abuhusain HJ; McDonald KL; Don AS, 2011, 'HIGH-THROUGHPUT LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY MEASUREMENTS OF BIOACTIVE LIPIDS INTEGRATED WITH GENE EXPRESSION DATA IN GLIOBLASTOMA', NEURO-ONCOLOGY, vol. 13, pp. 81 - 81, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600328&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Sevim H; Chung L; Wheeler HT; Baxter RC; McDonald KL, 2011, 'ABERRANT EXPRESSION OF LOW-MOLECULAR-WEIGHT PROTEINS ASSOCIATED WITH RESPONSE TO CONVENTIONAL CONCURRENT CHEMORADIOTHERAPY TREATMENT', NEURO-ONCOLOGY, vol. 13, pp. 79 - 80, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Lu D; Mreich E; Chung S; Teo C; Wheeler H; McDonald KL, 2011, 'MGMT PROMOTER METHYLATION AND DNA MISMATCH REPAIR IN PRIMARY AND RELAPSED GLIOBLASTOMA', NEURO-ONCOLOGY, vol. 13, pp. 16 - 17, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Chung SA; Dilda PJ; Ramsay EE; Teo C; Hogg PJ; McDonald KL, 2011, 'PENAO: A novel tumor metabolism inhibitor for glioblastoma', CANCER RESEARCH, vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-2604
Fowler A; Thomson D; Giles KM; Maleki S; Mreich E; Wheeler H; Leedman P; Biggs MT; Cook R; Little N; Robinson BG; McDonald K, 2011, 'MiR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion', European Journal of Cancer, vol. 47, pp. 953 - 963, http://dx.doi.org/10.1016/j.ejca.2010.11.026
Sevim H; Parkinson J; McDonald K, 2011, 'Etoposide-mediated glioblastoma cell death: Dependent or independent on the expression of its target, topoisomerase II alpha?', Journal of Cancer Research and Clinical Oncology, vol. 137, pp. 1705 - 1712, http://dx.doi.org/10.1007/s00432-011-1046-5
McDonald KL; McDonnell J; Muntoni A; Henson JD; Hegi ME; Von Deimling A; Wheeler HR; Cook RJ; Biggs MT; Little NS; Robinson BG; Reddel RR; Royds JA, 2010, 'Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival', Journal of Neuropathology and Experimental Neurology, vol. 69, pp. 729 - 736, http://dx.doi.org/10.1097/NEN.0b013e3181e576cf
Duncan CG; Killela PJ; Payne CA; Lampson B; Chen WC; Liu J; Solomon D; Waldman T; Towers AJ; Gregory SG; McDonald K; McLendon RE; Bigner DD; Yan H, 2010, 'Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes', Oncotarget, vol. 1, pp. 265 - 277, http://dx.doi.org/10.18632/oncotarget.137
Elston MS; Gill AJ; Conaglen JV; Clarkson A; Cook RJ; Little NS; Robinson BG; Clifton-Bligh RJ; McDonald KL, 2009, 'Nuclear accumulation of E-Cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas', Journal of Clinical Endocrinology and Metabolism, vol. 94, pp. 1436 - 1442, http://dx.doi.org/10.1210/jc.2008-2075
Soon PSH; Gill AM; Benn D; Clarkson A; Robinson B; Mcdonald K; Sidhu S, 2009, 'Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas', Endocrine - Related Cancer, vol. 16, pp. 573 - 583, http://dx.doi.org/10.1677/ERC-08-0237
McCormack A; McDonald K; Gill A; Clark SJ; Burt MG; Campbell K; Braund W; Little N; Cook R; Grossman AB; Robinson BG; Clifton-Bligh R, 2009, 'Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours', Clinical Endocrinology, vol. 71, pp. 226 - 233, http://dx.doi.org/10.1111/j.1365-2265.2008.03487.x
Payne CA; Maleki S; Messina M; O'Sullivan MG; Stone G; Hall NR; Parkinson JF; Wheeler HR; Cook RJ; Biggs MT; Little NS; Teo C; Robinson BG; McDonald KL, 2008, 'Loss of prostaglandin D
Elston MS; Gill AJ; Conaglen JV; Clarkson A; Shaw JM; Law AJJ; Cook RJ; Little NS; Clifton-Bligh RJ; Robinson BG; McDonald KL, 2008, 'Wnt pathway inhibitors are strongly down-regulated in pituitary tumors', Endocrinology, vol. 149, pp. 1235 - 1242, http://dx.doi.org/10.1210/en.2007-0542
Soon PSH; Mcdonald K; Robinson B; Sidhu S, 2008, 'Molecular markers and the pathogenesis of adrenocortical cancer.', Journal of Clinical Oncology, vol. 13, pp. 548 - 561, http://dx.doi.org/10.1634/theoncologist.2007-0243
Soon PSH; Libe R; Benn D; Gill A; Shaw J; Sywak M; Groussin L; Bertagna X; Gicquel C; Bertherat J; Mcdonald K; Sidhu S; Robinson B, 2008, 'Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B in the pathogenesis of adrenocortical tumors.', Annals of Thoracic Surgery, vol. 247, pp. 157 - 164, http://dx.doi.org/10.1097/SLA.0b013e318153ff55
Au A; McDonald K; Gill AM; Sywak M; Diamond T; Conigrave A; Clifton-Bligh R, 2008, 'PTH mutation with primary hyperparathyroidism and undetectable intact PTH', New England Journal of Medicine, vol. 359, pp. 1184 - 1186, http://dx.doi.org/10.1056/NEJMc0802570
McDonald KL; O'Sullivan MG; Parkinson JF; Shaw JM; Payne CA; Brewer JM; Young L; Reader DJ; Wheeler HT; Cook RJ; Biggs MT; Little NS; Teo C; Stone G; Robinson BG, 2007, 'IQGAP1 and IGFBP2: Valuable biomarkers for determining prognosis in glioma patients', Journal of Neuropathology and Experimental Neurology, vol. 66, pp. 405 - 417, http://dx.doi.org/10.1097/nen.0b013e31804567d7
Conference Papers
Jue TJ; Hirst TC; Sena ES; Macleod MR; McDonald KL, 2017, 'A SYSTEMATIC REVIEW AND META-ANALYSIS OF TOPOISOMERASE INHIBITION IN PRE-CLINICAL GLIOMA MODELS', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Zurich, SWITZERLAND, pp. 59 - 59, presented at 5th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology-Societies (WFNOS), Zurich, SWITZERLAND, 04 May 2017 - 07 May 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402732900215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Jue TJ; Chung SA; Rapkins RW; Dilda P; Hogg P; McDonald KL, 2017, 'TARGETING GLIOBLASTOMA MITOCHONDRIAL METABOLISM TO INHIBIT CELL PROLIFERATION & TUMOR GROWTH', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Zurich, SWITZERLAND, pp. 59 - 59, presented at 5th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology-Societies (WFNOS), Zurich, SWITZERLAND, 04 May 2017 - 07 May 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402732900214&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
McDonald KL; Khasraw M; Jue TR; Joshi S; Yin J, 2015, 'Genomically unstable glioblastoma are sensitive to Parp inhibition', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Washington, DC, presented at AACR Special Conference on Advances in Brain Cancer Research, Washington, DC, 27 May 2015 - 30 May 2015, http://dx.doi.org/10.1158/1538-7445.BRAIN15-A12
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ, 2014, 'Involvement of the kynurenine pathway in human glioma pathophysiology', in PLoS ONE, http://dx.doi.org/10.1371/journal.pone.0112945
Mallawaaratchy DM; McDonald KL; Sykes EK; Buckland ME; Christopherson RI; Kaufman KL, 2014, 'NOVEL PROTEINS ASSOCIATED WITH INVADOPODIA STRUCTURES IN GLIOBLASTOMA MULTIFORME', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Turin, ITALY, presented at 11th Congress of the European-Association-of-Neuro-Oncology, Turin, ITALY, 09 October 2014 - 12 October 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344235700384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Kaufman KL; Ly L; McKay M; Mallawaaratchy DM; Mactier S; Crossett B; Molloy M; Buckland ME; McDonald KL; Christopherson RI, 2014, 'COMPREHENSIVE PROTEOMIC PROFILING OF BEVACIZUMAB-RESISTANT GLIOBLASTOMA MULTIFORME', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Turin, ITALY, presented at 11th Congress of the European-Association-of-Neuro-Oncology, Turin, ITALY, 09 October 2014 - 12 October 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344235700377&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
McDonald KL; Ha W; Sevim H, 2014, 'MIF-CD74 GUIDED THERAPEUTIC STRATEGY FOR THE UPFRONT TREATMENT OF GBM PATIENTS WITH AN UNMETHYLATED MGMT PROMOTER', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, CA, presented at 20th International Conference on Brain Tumor Research and Therapy, CA, 20 July 2014 - 22 July 2014, http://dx.doi.org/10.1093/neuonc/nou206.15
Nozue-Okada K; Nagane M; McDonald KL, 2013, 'COMBINING PARP INHIBITORS WITH TMZ: IMPROVED EFFICACY OBSERVED IN RECURRENT PATIENT-DERIVED CELL LINES COMPARED TO PRIMARY CELLS', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, San Francisco, CA, pp. 54 - 54, presented at 4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO) held in conjunction with the 18th Annual Meeting of the Society-for-Neuro-Oncology (SNO), San Francisco, CA, 21 November 2013 - 24 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327456200226&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Shen H; Luk PP; Chung SA; Decollogne S; Dilda PJ; Hogg PJ; McDonald KL, 2013, 'PENAO, a novel mitochondria-targeted agent, has shown potent antitumor effect on glioblastoma in vitro and in vivo', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Washington, DC, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-1701
Conference Presentations
Shen H; Hau E; Dilda P; McDonald K, 2014, 'SENSITIZATION OF GLIOBLASTOMA CELLS TO IRRADIATION BY MODULATING THE GLUCOSE METABOLISM', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Vol. 16, http://dx.doi.org/10.1093/neuonc/nou255.53
Conference Abstracts
Ashley DM; Muscat A; Yin J; Algar E; Drummond K; Khasraw M; Field KM; Wong N; Rosenthal M; McDonald KL, 2015, 'Mutational analysis of matched initial and recurrent TP53 WT primary GBM.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Chicago, IL, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.2043
Khanna A; Stringer B; Day B; Ensbey K; Shen H; Boyd A; McDonald KL; Pimanda J, 2014, 'Keeping GBM in check by targeting CHK1-CIP2A axis', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Chicago, IL, Vol. 32, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 30 May 2014 - 03 June 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358613202702&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Chung SA; Luk PP; Shen H; Decollogne S; Day BW; Stringer BW; Hogg PJ; Dilda PJ; McDonald KL, 2012, 'PENAO: A POTENT ARSENICAL-BASED INHIBITOR FOR GLIOBLASTOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Marseille, FRANCE, Vol. 14, pp. 47 - 47, presented at 10th Congress of the European-Association-of-NeuroOncology, Marseille, FRANCE, 06 September 2012 - 09 September 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308545600174&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Luk PP; Chung SA; Shen H; Decollogne S; Dilda PJ; McDonald KL; Hogg PJ, 2012, 'Blocking ATP delivery to hexokinase II in glioblastoma is a promising therapeutic strategy', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-1131
Chung SA; McDonald KL; Shen H; Day BW; Stringer BW; Johns T; Decollogne S; Teo C; Hogg PJ; Dilda PJ, 2011, 'TARGETING GLIOBLASTOMA METABOLISM WITH A NOVEL ARSENIC-BASED METABOLIC INHIBITOR, PENAO', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Vol. 13, pp. 118 - 118, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600469&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Prince of Wales Clinical School, UNSW Medicine NSW 2052 Australia | Authorised by Head of School | CRICOS Provider Code: 00098G | ABN: 57 195 873 179 Page last updated: Sunday 22 May 2022